Nancy Valente
Board Member
Xencor Inc (XNCR)Equibles does not estimate personal net worth.
Get an email with a short summary when Xencor Inc publishes a filing, an earnings call transcript or a press release.
Get XNCR alertsAbout Nancy Valente
Nancy Valente is recorded as Board Member at Xencor Inc (XNCR) since September 8, 2022. Xencor Inc reported in an 8-K filed May 7, 2025 that Nancy Valente resigned as Executive Vice President and Chief Development Officer, effective June 6, 2025. Xencor Inc reported in an 8-K filed April 26, 2023 that Nancy Valente was appointed Executive Vice President and Chief Development Officer, effective May 1, 2023. Xencor Inc reported in an 8-K filed April 26, 2023 that Nancy Valente resigned as Board of Directors, effective May 1, 2023. Equibles holds 4 filed executive changes naming Nancy Valente; each is listed under recent activity with its source filing. The proxy statement of Xencor Inc reports total compensation of $430,766 for Nancy Valente in fiscal 2025, including a base salary of $249,421. Disclosed compensation is on record for 3 fiscal years. Xencor Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Xencor Inc includes Dr. Bassil I. Dahiyat (CEO and Board Member), Bart Cornelissen (CFO), Bart Jan Cornelissen (CFO) and 7 others.
“On May 5, 2025, Nancy Valente, Executive Vice President and Chief Development Officer, notified the Company of her intention to resign from the Company effective June 6, 2025, and remain as a senior advisor.”
“On April 24, 2023, Dr. Nancy Valente, age 64, was appointed as Executive Vice President and Chief Development Officer of the Company, effective May 1, 2023 (the "Start Date") for an indefinite term.”
Affiliation history
-
Current
2022-09-08–present
-
2022-09-08–2023-05-01
-
Xencor Inc (XNCR)
Proxy statement
Start not stated–2025-06-06
Company network
Leadership on record at Xencor Inc
- Dr. Bassil I. Dahiyat CEO, Board Member
- Bart Cornelissen CFO
- Bart Jan Cornelissen CFO
- Celia E. Eckert General Counsel
- Barbara Klencke, M.D. Board Member
- Dr. A. Bruce Montgomery Board Member
- Dr. Barbara Klencke Board Member
- Dr. Ellen G. Feigal Board Member
- Dr. Kevin C. Gorman Board Member
- Dr. Raymond J. Deshaies Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xencor Inc (XNCR) | Former Chief Development Officer | $249,421 | $430,766 |
| 2024 | Xencor Inc (XNCR) | Chief Development Officer | $556,200 | $2,867,773 |
| 2023 | Xencor Inc (XNCR) | Chief Development Officer | $360,000 | $5,168,862 |